Relatively young patients develop antipsychotic ‐related movement disorders

Little is known about the impact of antipsychotic medication on movement disorders in young patients a few years after disease onset, but a recent study shows a surprisingly high rate of such disorders in young people only four years after the onset of the disease. Researchers used the Genetic Risk and Outcome of Psychosis (GROUP) study to assess the prevalence, incidence, persistence, and clinical correlates of drug‐related movement disorders on young patients.

Source: The Brown University Child and Adolescent Psychopharmacology Update - April 24, 2017 Category: Psychiatry Tags: What's New in Research Source Type: research